Clinical trial
Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO)
To evaluate the safety of allopurinol at medically appropriate doses (at least 200 mg daily).
| Category | Value |
|---|---|
| Study start date | 2011-08-02 |